Morgan Keegan has a Market Perform rating and a $78 price target on shares of HMS Holdings Corp. HMSY.
In a note to clients, Morgan Keegan writes, "HMSY has identified three areas related to health reform that could benefit the company before 2014: enrollment growth, Medicaid RAC and insurance exchanges. In this note, we look at the potential for early adoption of broader Medicaid eligibility requirements to drive enrollment growth before 2014."
Shares of HMSY closed at $80.40 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in